Dow Jones Newswires: AstraZeneca says cancer drug Enhertu showed positive results

Portrait of beautiful smiling couple hugging at Christmas eve. Beautiful young couple at home enjoying spending time together. Winter holidays, Christmas celebrations, New Year concept.

Enhertu–trastuzumab deruxtecan, which it is jointly developing and commercializing with Daiichi Sankyo–had met prespecified criteria for objective response rate and duration of response.

You might also like